Status:
COMPLETED
A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
40-65 years
Phase:
PHASE1
Brief Summary
This trial is conducted in Europe and Japan. The aim of this clinical trial is to investigate the possible difference in the development of type 2 diabetes in a Japanese and a Caucasian population. He...
Eligibility Criteria
Inclusion
- Danish (Northern European) or Japanese (according to country allocation) background for at least 3 generations
- BMI above or equal to 18 kg/m2
Exclusion
- Treatment of diabetes mellitus with any insulin product
- Fasting plasma/serum glucose above 12 mM
- Therapy with TZD (thiazolidinedione) drugs within the past 3 months
- Therapy with more than 2 OADs (oral anti-diabetics drugs)
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
271 Patients enrolled
Trial Details
Trial ID
NCT00897169
Start Date
June 1 2009
End Date
December 1 2010
Last Update
October 27 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
København Ø, Denmark, 2100
2
Novo Nordisk Investigational Site
Tokyo, Japan, 113-8655